These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9829615)
21. Lactulose as a marker of intestinal barrier function in pigs after weaning. Wijtten PJ; Verstijnen JJ; van Kempen TA; Perdok HB; Gort G; Verstegen MW J Anim Sci; 2011 May; 89(5):1347-57. PubMed ID: 21257783 [TBL] [Abstract][Full Text] [Related]
22. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Lin R; Zhou L; Zhang J; Wang B Int J Clin Exp Pathol; 2015; 8(5):5153-60. PubMed ID: 26191211 [TBL] [Abstract][Full Text] [Related]
23. Effects of recombinant human growth hormone on intestinal translocation of bacteria and endotoxin in rats with obstructive jaundice. Yang ZW; Li JG; Mao XG; Sun B; Tong ZS; Sun HY; Li XR; Cong YP Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):445-9. PubMed ID: 16109534 [TBL] [Abstract][Full Text] [Related]
25. Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Natividad JM; Verdu EF Pharmacol Res; 2013 Mar; 69(1):42-51. PubMed ID: 23089410 [TBL] [Abstract][Full Text] [Related]
26. The pathogenesis of gastrointestinal bacterial overgrowth. Husebye E Chemotherapy; 2005; 51 Suppl 1():1-22. PubMed ID: 15855746 [TBL] [Abstract][Full Text] [Related]
27. Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study. Thalheimer U; De Iorio F; Capra F; del Mar Lleo M; Zuliani V; Ghidini V; Tafi MC; Caburlotto G; Gennari M; Burroughs AK; Vantini I Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1228-34. PubMed ID: 20512041 [TBL] [Abstract][Full Text] [Related]
30. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726 [TBL] [Abstract][Full Text] [Related]
31. The gut barrier: new acquisitions and therapeutic approaches. Scaldaferri F; Pizzoferrato M; Gerardi V; Lopetuso L; Gasbarrini A J Clin Gastroenterol; 2012 Oct; 46 Suppl():S12-7. PubMed ID: 22955350 [TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal mucormycosis in an infant. Mohta A; Neogi S; Das S Indian J Pathol Microbiol; 2011; 54(3):664-5. PubMed ID: 21934265 [No Abstract] [Full Text] [Related]
33. [Influence of intra-abdominal hypertension on the intestinal permeability and endotoxin/bacteria translocation in rabbits]. Cheng JT; Xiao GX; Xia PY; Yuan JC; Qin XJ Zhonghua Shao Shang Za Zhi; 2003 Aug; 19(4):229-32. PubMed ID: 14514405 [TBL] [Abstract][Full Text] [Related]
34. Corticotropin-releasing factor is present in intestinal tissue of patients with gastrointestinal dysfunction following shock and abdominal surgery. Hill LT; Kidson SH; Michell WL Nutrition; 2013 Apr; 29(4):650-4. PubMed ID: 23466050 [TBL] [Abstract][Full Text] [Related]
35. Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial. Diepenhorst GM; van Ruler O; Besselink MG; van Santvoort HC; Wijnandts PR; Renooij W; Gouma DJ; Gooszen HG; Boermeester MA Shock; 2011 Jan; 35(1):9-16. PubMed ID: 20577144 [TBL] [Abstract][Full Text] [Related]
37. Altered intestinal function in patients with chronic heart failure. Sandek A; Bauditz J; Swidsinski A; Buhner S; Weber-Eibel J; von Haehling S; Schroedl W; Karhausen T; Doehner W; Rauchhaus M; Poole-Wilson P; Volk HD; Lochs H; Anker SD J Am Coll Cardiol; 2007 Oct; 50(16):1561-9. PubMed ID: 17936155 [TBL] [Abstract][Full Text] [Related]
38. Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis. Gómez-Hurtado I; Moratalla A; Moya-Pérez Á; Peiró G; Zapater P; González-Navajas JM; Giménez P; Such J; Sanz Y; Francés R J Hepatol; 2014 Oct; 61(4):799-808. PubMed ID: 24882049 [TBL] [Abstract][Full Text] [Related]
39. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Besselink MG; van Santvoort HC; Renooij W; de Smet MB; Boermeester MA; Fischer K; Timmerman HM; Ahmed Ali U; Cirkel GA; Bollen TL; van Ramshorst B; Schaapherder AF; Witteman BJ; Ploeg RJ; van Goor H; van Laarhoven CJ; Tan AC; Brink MA; van der Harst E; Wahab PJ; van Eijck CH; Dejong CH; van Erpecum KJ; Akkermans LM; Gooszen HG; Ann Surg; 2009 Nov; 250(5):712-9. PubMed ID: 19801929 [TBL] [Abstract][Full Text] [Related]